ranluspec
Pharmaranks rates Ranluspec 3.2/5 for recall safety — an independent score from its FDA recall history and its manufacturer's record. Ranluspec (Ranibizumab-Hkdz) is a medication supplied as an injection.
Ranibizumab-Hkdz · by Lupin
Based on 1 source · Recall-safety score from FDA recall history — this product's own recalls and its manufacturer's record. Not an efficacy or quality rating. methodology →
Key facts
- Active ingredient
- Ranibizumab-Hkdz
- Form
- Injectable
- Strength
- RANIBIZUMAB-HKDZ 10MG/ML · RANIBIZUMAB-HKDZ 6MG/ML
- Type
- Prescription (Rx)
- Brand or generic
- Brand-name
- Manufacturer
- Lupin
- FDA application
- BLA761480
Dosage forms
Injectable
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- How is Ranluspec rated?
- pharmaranks gives Ranluspec a composite score of 3.2 out of 5, currently based on 1 weighted source (FDA regulatory recall-safety data weighted highest). See our methodology at /how-we-rate.
- Is there a coupon or discount for Ranluspec?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Ranluspec. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Ranluspec?
- Ranluspec is marketed by Lupin. You can see Lupin's full profile, rating, and other products on pharmaranks.
- Is Ranluspec a brand-name or generic drug?
- Ranluspec is a brand-name product with the active ingredient Ranibizumab-Hkdz.
- Is Ranluspec available over the counter?
- No. Ranluspec is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Ranluspec come in?
- Ranluspec is currently marketed as injectable, per the FDA's National Drug Code Directory.
- Is Ranluspec FDA-registered?
- Ranluspec is on record with the U.S. FDA under application number BLA761480. You can verify this on its official FDA label.
- Has Ranluspec been recalled by the FDA?
- Ranluspec has no FDA recalls recorded under its own application in the openFDA enforcement database. Its recall-safety score reflects its manufacturer's overall recall record. This is general reference, not medical advice — check the FDA recall database for the latest alerts.
- Is Ranluspec safe?
- There's no single safe-or-not verdict. pharmaranks gives Ranluspec a recall-safety score of 64/100, based on its FDA recall history (no recalls under its own FDA application) — not an efficacy or side-effect rating. Review its FDA-label side effects and warnings before use, and always consult a licensed professional.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
Reviews
No reviews yet. Be the first to write one.
People also viewed
abiraterone acetate
Abiraterone Acetate
acular
Ketorolac Tromethamine
acular ls
Ketorolac Tromethamine
aimovig
Erenumab-Aooe
albendazole
Albendazole
alphagan p
Brimonidine Tartrate
Compare Ranluspec head-to-head
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
ranluspec
64/100